Voyager Therapeutics's Cancer Antibody Program Shows Encouraging Preclinical Action


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


  • Voyager Therapeutics Inc (NASDAQ:VYGRannounced preclinical data from a new vectorized anti-HER2 antibody program.
  • Data showed that IV dosing of a proprietary AAV vector identified by the TRACER screening technology, encoding an anti-HER2 antibody payload, prevented tumor growth in animal models of brain metastases. 
  • Peripheral administration of TRACER AAV vector resulted in the production of efficacious levels of HER2-directed antibodies for extended periods.
  • Related: Voyager Therapeutics Stock Soars On License Option Pact With Pfizer.
  • Price Action: VYGR shares are up 3.16% at $3.26 during the premarket session on the last check Friday.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechNewsPenny StocksHealth CareMoversTrading IdeasGeneralBriefsPreclinical Phase